Impact of Generalized Pustular Psoriasis (GPP) on the Quality of Life

This is a video synopsis/summary of a panel discussion involving Tina Bhutani, MD; J. Scott Boswell, MD; and Kanya Oul, RN.

The discussion centers on the profound impact of psoriasis, particularly plaque psoriasis and generalized pustular psoriasis (GPP), on patients' quality of life. The conversation explores how these conditions lead to feelings of embarrassment and stigma, affecting patients' mental health and overall well-being. Kanya, who has experienced psoriasis since childhood, shares her personal journey, highlighting the challenges of managing flare-ups and the persistent mental toll of living with a chronic disease.

Despite efforts to control her condition with treatments like isotretinoin, Kanya still grapples with feelings of self-consciousness and depression. She recounts instances of hiding her skin and enduring insensitive comments from others, emphasizing the ongoing struggle to feel comfortable in her own body. Even during periods of remission, Kanya experiences lingering reminders of her condition, such as post-inflammatory hyperpigmentation, which further affects her confidence and self-image.

The speaker acknowledges the complex interplay between physical symptoms and mental health, noting the heightened prevalence of depression and anxiety among psoriasis patients. He stresses the importance of addressing these psychological aspects in patient care, advocating for comprehensive support that includes mental health interventions alongside medical treatment.

The dialogue underscores the need for healthcare providers to consider the holistic impact of psoriasis on patients' lives, beyond just the physical symptoms. By recognizing and addressing the emotional and psychological toll of the disease, clinicians can better support patients in managing their condition and improving their overall quality of life.

Video synopsis is AI-generated and reviewed by HCPLive editorial staff.